Get 50% OFF This Monsoon!

Advertisement
AdvertisementAdvertisement
logo

Krsnaa Diagnostics

KRSNAA
Small Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement
AdvertisementAdvertisement

Krsnaa Diagnostics Share price and Fundamental Analysis

View All Details
View All Details
Krsnaa Diagnostics Limited was originally incorporated as Krsna Diagnostics Private Limited' at Pune, Maharashtra as a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated 22 December 2010. The name of the Company was subsequently changed to Krsnaa Diagnostics Private Limited', pursuant to a fresh certificate of incorporation issued by the RoC on 29 January 2015. Thereafter, the Company was converted into a public limited company pursuant to a special resolution passed in the extraordinary general meeting of the Shareholders of our Company held on 25 April 2021 and consequently the name of the Company was changed to its present name pursuant to a fresh certificate of incorporation issued by the RoC on 06 May 2021. The company is primarily engaged in providing diagnostic services centres all over India.The company is providing Radiology and Pathology services for X-ray,CT scan,MRI,Mammography,Tele-Reporting services,all type of blood and urine investigation and other related diagnostic services. The company owns an extensive network of integrated diagnostics centres across India primarily in non-metro and lower-tier cities and towns,with operating 1823 diagnostics centres offering radiology and pathology services in 13 states across the country.The company focuses on the public-private partnership(PPP) diagnostics segment and has the largest presence in the diagnostic PPP segment.
Company Incorporation2010
ChairmanRajendra Mutha
Head QuartersNA
Previous NameNA

Key Metrics

Market Cap (Cr)
2,064.93
PE Ratio
26.61
Industry P/E
45.8
PEG Ratio
0.73
ROE
8.79%
ROCE
11.5%
ROA
6.06%
Total Debt (Cr)
201.62
Debt to Equity
0.23
Dividend Yield
0.43%
EPS
24.03
Book Value & P/B
276.65 x 2.31
Face Value
5
Outstanding Shares(Cr)
3.23
Current Ratio
2.78
EV to Sales
3.06

Included In

+More

Stock Returns

1 Week-0.5%
1 Month-10.09%
6 Months-35.9%
1 Year+18.91%
3 Years+14.84%
5 Years-35.14%

CAGR

1 Year CAGR

Revenue Growth

+27.2%

Net Profit Growth

-8.49%

Operating Profit Growth

+13.67%

Dividend Growth

-9.09%

Stock Returns CAGR

+18.91%
no_data

No Stocks

Smart Score

2
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

/ View Standalone
PARTICULARS

Total Revenue

Total Expenses

Operating Expense

Operating Profit

Interest

Depreciation & Amortization

Profit Before Tax

Tax

Profit after tax

Adj EPS in Rs - Basic

Adj EPS in Rs - Diluted

Profit and Loss Statement

/ View Standalone
Credit Rating
Director Report
Chairman Report
Auditor Report

Balance sheet

/ View Standalone

Cashflow Statement

/ View Standalone
Mar 25

Promoters : 27.24%

FIIs : 3.55%

DIIs : 14.26%

Public : 54.94%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in March 2025 Qtr
FII Shareholding Decreased by 0.49% to 3.55% in March 2025 Qtr
DII Shareholding Decreased by 0.2% to 14.26% in March 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Krsnaa Diagnostics Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Krsnaa Diagnostics Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Krsnaa Diagnostics Limited was originally incorporated as Krsna Diagnostics Private Limited' at Pune, Maharashtra as a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated 22 December 2010. The name of the Company was subsequently changed to Krsnaa Diagnostics Private Limited', pursuant to a fresh certificate of incorporation issued by the RoC on 29 January 2015. Thereafter, the Company was converted into a public limited company pursuant to a special resolution passed in the extraordinary general meeting of the Shareholders of our Company held on 25 April 2021 and consequently the name of the Company was changed to its present name pursuant to a fresh certificate of incorporation issued by the RoC on 06 May 2021. The company is primarily engaged in providing diagnostic services centres all over India.The company is providing Radiology and Pathology services for X-ray,CT scan,MRI,Mammography,Tele-Reporting services,all type of blood and urine investigation and other related diagnostic services. The company owns an extensive network of integrated diagnostics centres across India primarily in non-metro and lower-tier cities and towns,with operating 1823 diagnostics centres offering radiology and pathology services in 13 states across the country.The company focuses on the public-private partnership(PPP) diagnostics segment and has the largest presence in the diagnostic PPP segment.

During the FY2019, the Company has issued 1000 equity shares of face value of Rs. 10/- each at an offer price of Rs. 328.9597 (including Security Premium of Rs. 318.9597/-). The company also issued 30,38,886 Compulsory Convertible Participating Preference Shares [CCPS] of face value of Rs. 250 each at an offer price of Rs. 328.9597 (including Security Premium of Rs. 78.9597).

During the FY2021,the company has allotted 730904 equity shares of Rs 10 each through rights issue. Also the company undertook the conversion of 600960 CCPS -Series B into equity shares in the ratio of 1:1 at a price of Rs 250 per share(including the premium of Rs 240 per share). The company,pursuant to a shareholders' resolution dated 25 April 2021,sub-divided the face value of equity shares from Rs 10 to Rs 5 per share.

During the month of August 2021,the company came out with Rs 1213.33 crore IPO which comprised a fresh issue of Rs 400 crore and an offer for sale of Rs 813.33 crore by selling shareholders,including PHI Capital Trust,Kitara and Somerset Indus Healthcare Fund.The company will utilise the fresh issue proceeds for establishing diagnostics centres in Punjab,Karnataka,Himachal Pradesh and Maharashtra and also repaying of debts.The allotted shares were listed on the BSE Ltd and National Stock Exchange of India(NSE) on 16 August 2021.

Krsnaa Diagnostics Share Price

Krsnaa Diagnostics share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Krsnaa Diagnostics Market Cap

Market capitalization of Krsnaa Diagnostics indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Krsnaa Diagnostics is valued compared to its competitors.

Krsnaa Diagnostics PE Ratio

Krsnaa Diagnostics PE ratio helps investors understand what is the market value of each stock compared to Krsnaa Diagnostics 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Krsnaa Diagnostics PEG Ratio

The PEG ratio of Krsnaa Diagnostics evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Krsnaa Diagnostics ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Krsnaa Diagnostics generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Krsnaa Diagnostics ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Krsnaa Diagnostics in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Krsnaa Diagnostics Total Debt

Total debt of Krsnaa Diagnostics shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Krsnaa Diagnostics Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Krsnaa Diagnostics compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Krsnaa Diagnostics CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Krsnaa Diagnostics over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Krsnaa Diagnostics Technical Analysis

Technical analysis of Krsnaa Diagnostics helps investors get an insight into when they can enter or exit the stock. Key components of Krsnaa Diagnostics Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Krsnaa Diagnostics shares often struggle to rise above due to selling pressure.

Krsnaa Diagnostics Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Krsnaa Diagnostics ’s financial health and profitability.

Krsnaa Diagnostics Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Krsnaa Diagnostics Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Krsnaa Diagnostics Financials

The financials of Krsnaa Diagnostics provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Krsnaa Diagnostics Profit and Loss Statements

The profit and loss statement of Krsnaa Diagnostics highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Krsnaa Diagnostics .

Krsnaa Diagnostics Balance Sheet

The balance sheet presents a snapshot of Krsnaa Diagnostics ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Krsnaa Diagnostics Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.

Download the App

Download the App